Kexing Biopharm Co., Ltd. (SHA:688136)
China · Delayed Price · Currency is CNY 16.00
+0.47 (3.03%)
Nov 5, 2026, 3:00 PM CST
Kexing Biopharm Market Cap
Kexing Biopharm has a market cap or net worth of 3.18 billion as of November 5, 2026. It is the 14,764th most valuable company in the world and the 3,959th biggest in China. Its market cap has decreased by 58.35% in one year.
Market Cap
3.18B
Enterprise Value
4.02B
Revenue
1.30B
Global Rank
Country Rank
#3,959 China
PE Ratio
45.08
ChartMarket Cap Chart
Since December 14, 2020, Kexing Biopharm's market cap has decreased from 8.15B to 3.18B, a decrease of -61.01%. That is a compound annual growth rate of -14.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 3.18B | -49.36% |
| Dec 31, 2025 | 6.27B | 45.13% |
| Dec 31, 2024 | 4.32B | 7.17% |
| Dec 29, 2023 | 4.03B | -5.31% |
| Dec 30, 2022 | 4.26B | -24.16% |
| Dec 31, 2021 | 5.62B | -30.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Baolingbao Biology | 3.22B |
| Pulike Biological Engineering | 3.19B |
| Shanghai Serum Bio-Technology | 3.16B |
| Jiangsu Sihuan Bioengineering | 3.13B |
| Hinova Pharmaceuticals | 2.95B |
| Xiangxue Pharmaceutical | 2.94B |
| Shanghai Shen Lian Biomedical | 2.93B |
| Qingdao Vland Biotech INC. | 2.92B |